Fig. 1From: Mydriasert pupillary dilation for cataract surgery: an economic and clinical studyBudget impact model structure. The model follows a cohort of patients, and calculates the drug, consumable and staff costs for achieving mydriasis using Mydriasert and eye drops (tropicamide [1 %] and phenylephrine [10 %]). The structure of the analysis aimed to incorporate all costs and outcomes relevant to the NHS and to capture any significant differences in costs between treatmentsBack to article page